Search Results
Jodi Daniel
Partner
Jodi Daniel is a nationally recognized leader in digital health law and policy, trusted by health care organizations and technology innovators to navigate the complex and dynamic regulatory landscape of digital health and wellness. With over 30 years of experience in healthcare innovation—including 15 years as a lawyer and senior policymaker at the U.S. Department of Health and Human Services (HHS)—Jodi leverages her extensive experience in digital health and health data to deliver strategic, practical advice to clients engaged in groundbreaking products and services that raise novel legal, policy, and ethical issues.
Andrea Linna
Partner
Andrea Linna is a partner at Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s digital health industry group and its healthcare practice. With more than a decade dedicated to healthcare law, Andrea exclusively represents digital health and healthcare IT clients, from emerging companies to established industry players, investors, and healthcare systems. Andrea guides her clients through the patchwork of federal and state laws that apply to digital health companies, addressing issues such as corporate practice of medicine, Stark Law compliance, Anti-Kickback Statute considerations, fee splitting, billing Medicare and Medicaid, contracting with commercial payors, value-based care arrangements, artificial intelligence, remote patient monitoring, online prescribing, scope of practice, and licensing requirements.
Eva F. Yin
Partner
Eva Yin, Ph.D., M.P.H., is a partner in Wilson Sonsini Goodrich & Rosati’s FDA regulatory, healthcare, and consumer products practice. Her practice includes conducting FDA and healthcare regulatory due diligence for corporate transactions; providing legal counsel to manufacturers regarding FDA approval/clearance for various products—including medical devices, mobile apps, and drugs, FDA compliance, regulation of promotional materials and labeling, and manufacturer compliance under federal and state healthcare laws, e.g., the federal Anti-Kickback Statute (AKS), False Claims Act (FCA), Sunshine Act, state licensing laws, corporate practice of medicine, etc.; reviewing contracts and compliance policies for manufacturers; and providing legal analysis and risk assessment of business models and fee arrangements involving patient assistance programs, healthcare professionals, or hospitals/clinics under federal and state healthcare laws and regulations.
Rob Parr
Partner
Rob Parr is a partner in the Boston office of Wilson Sonsini Goodrich & Rosati, where he leads the office’s information technology transactions practice. He represents companies in transactions focused on the exploitation of intellectual property rights and technology in a variety of industries. Rob represents many companies in the digital health industry in particular and plays a key role in the firm’s digital health initiative. He regularly drafts and negotiates a wide variety of complex commercial agreements, including services, distribution, strategic alliance and joint venture, supply, asset transfer, and intellectual property license agreements. Rob also represents clients with the intellectual property and commercial issues arising from financings, mergers, acquisitions, and initial public offerings.
Megan J. Baier
Partner
Megan represents technology and life sciences clients in corporate transactional matters.
Mark B. Baudler
Partner
Mark is a corporate law veteran, having advised start-ups and mature public companies for more than 25 years.
Farah B. Gerdes
Partner
Farah focuses on the representation of pharmaceutical, biotechnology, medical device, and diagnostic companies in complex collaboration and partnering transactions.
Ali R. Alemozafar
Partner
Ali counsels clients on patent strategy, prosecution, and diligence for financings, M&A, and IPOs.
Salil Gandhi
Partner
Salil Gandhi is a partner in the New York office of Wilson Sonsini Goodrich & Rosati and a co-leader of the firm’s emerging companies practice. Salil focuses on corporate and securities law and specializes in the representation of emerging growth companies throughout their lifecycles, particularly in the life sciences and technology sectors. He also counsels venture capital funds and other private equity funds on structuring and executing investment transactions ranging from angel to control investments, as well as portfolio dispositions.
Daniel Glazer
Partner
Daniel counsels UK and European tech and life sciences companies on U.S. expansion and fundraising.
Jeana S. Kim
Partner
Jeana’s practice focuses on corporate and securities law matters for emerging growth companies, venture capital firms, and public companies.
Scott A. McKinney
Partner
Scott focuses on complex commercial and technology transactions and frequently advises companies with new and emerging technologies.
Melissa Rick
Partner
Melissa Rick is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where her practice focuses on corporate and securities transactions, with particular emphasis on the life sciences and technology industries. She advises emerging companies at all stages of maturity, including formation, initial funding, expansion, and exit. Melissa works with public and private companies on a range of transactions, including venture financings, initial public offerings, and mergers and acquisitions. She also counsels clients on matters such as general corporate law and governance and public company disclosure, as well as reporting with the U.S. Securities and Exchange Commission.
Lidia Niecko-Najjum
Of Counsel
Lidia Niecko-Najjum is Of Counsel in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she provides strategic counseling on health care regulatory and policy matters. Lidia is a seasoned attorney and former nurse with over 15 years of legal and policy experience. Her practice is focused on data use, interoperability, information blocking, privacy and security, artificial intelligence, machine learning, digital therapeutics, and telehealth. Her representative clients include digital health companies, health information networks, health plans, health systems, and academic medical centers.
Yoichiro (Yokum) Taku
Partner
Yokum focuses on helping technology and growth companies at all stages of development.
Nawa Lodin
Associate
Nawa Lodin is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s digital health industry group and healthcare practice. She advises healthcare, digital health, life sciences, and technology companies on complex healthcare regulatory and transactional matters, with a particular focus on artificial intelligence and machine learning in healthcare, telehealth, corporate practice of medicine, and federal and state fraud and abuse laws, including the Anti-Kickback Statute and Stark Law.
Hale Melnick
Associate
Hale Melnick is an associate in the privacy and cybersecurity group of Wilson Sonsini Goodrich & Rosati. He primarily advises digital health companies across a range of privacy, transactional, research, and health care regulatory issues. In particular, Hale leverages his expertise in HIPAA, the CCPA, the GDPR, and other state, national, and international privacy laws and regulations to provide early-stage companies with practical day-to-day support in the area of health care.
Mark W. Bellomy
Partner
Mark Bellomy is a partner in Wilson Sonsini Goodrich & Rosati’s Boston office, where he is a member of the technology transactions practice. Mark advises numerous domestic and international public and private biopharmaceutical, medtech, digital health, medical device, and life sciences companies on all of the transactions related to the discovery, development, supply, and commercialization of their products, technologies, and services. He counsels clients with respect to structuring and negotiating a wide range of arrangements designed to maximize the value of their businesses.
John M. Brust
Partner
John counsels start-ups in a wide range of matters, from formation and VC to IPOs and M&A.
James G. Clessuras
Partner
James assists clients with transactions driven by use or acquisition of technology and IP rights.
Robert G. Day
Partner
Bob represents companies and financial services entities, from innovative entrepreneurs to investment banks and venture capital and private equity firms.
Mark R. Fitzgerald
Partner
Mark is a veteran attorney who advises technology and life sciences companies on corporate law and transactional matters.
Bryan D. King
Partner
Bryan focuses on corporate and securities law matters for emerging growth companies, venture capital firms, and public companies.
Michael C. Labriola
Partner
Michael Labriola is a partner with Wilson Sonsini Goodrich & Rosati, where he counsels public and private technology, life sciences, and emerging growth companies through all stages of their growth. Michael has particular experience with Wilson Sonsini’s clients across the U.S. East Coast and Europe. He has a particular focus on supporting companies that undertake transformative events, such as growth financings, IPOs, acquisitions, and exit sales. Michael counsels clients in matters ranging from formation and early-stage venture financing to listings of publicly traded securities on U.S. and foreign exchanges to seasoned public offerings and private and public company acquisitions. He also has considerable experience in counseling publicly held companies on disclosure matters, SEC compliance, Nasdaq and NYSE listing matters, and other securities laws issues. In addition, Michael frequently represents investment banks, venture capital funds, and private equity firms in a broad range of investment transactions.
Scott K. Murano
Partner
Scott advises clients in a broad range of corporate transactions and related matters.
Danielle Naftulin
Partner
Danielle Naftulin is a partner in the Palo Alto office of Wilson Sonsini with over 25 years of experience advising emerging companies and venture capital investors on a broad range of corporate transactions. Her practice focuses on the representation of high-growth life sciences and technology companies and their investors in formation and financing matters, as well as mergers and acquisitions, recapitalizations, spinouts, and general corporate matters. She has also represented clients in connection with initial public offerings and other public financing and strategic transactions.
Prior to joining the firm, Danielle was a partner in the business department at Cooley LLP in Palo Alto. She is an active member of the National Venture Capital Association’s General Counsel Advisory Board and a regular speaker on emerging companies and venture capital for Practising Law Institute, various law schools, and other organizations.
Prior to joining the firm, Danielle was a partner in the business department at Cooley LLP in Palo Alto. She is an active member of the National Venture Capital Association’s General Counsel Advisory Board and a regular speaker on emerging companies and venture capital for Practising Law Institute, various law schools, and other organizations.
Philip H. Oettinger
Partner
Philip focuses primarily on the representation of medical device, biotechnology, pharmaceutical, diagnostic, and digital health companies in corporate governance, IPO, M&A, public company reporting, and private equity and debt financing matters.
Jeffrey D. Saper
Partner
Jeff specializes in public and private financings of technology and other emerging growth companies, as well as the representation of leading investment banks and corporate issuers in public offerings and M&A transactions.
Elton Satusky
Partner
Elton specializes in public and private corporate finance and corporate law and governance. He also has considerable M&A and venture capital experience.
Travis L. Scheft
Partner
Travis Scheft is a partner in the San Francisco office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law and focuses primarily on start-ups, venture capital transactions, capital markets, corporate finance, and mergers and acquisitions.
Lowell Segal
Partner
Lowell represents pharmaceutical, biotechnology, medical device, and other technology-based companies in a wide range of strategic transactions and corporate matters.
Craig E. Sherman
Partner
Craig represents companies, venture capital firms, and investment banks in private placements and public offerings. He also has M&A, technology licensing, and domestic and international joint venture experience.